Related Experiment Video
Updated: Aug 14, 2025

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era
Tao Huang1, Xin Li1, Michael Maier1
1Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia.
Abstract:
Fungal infections pose a serious threat to human health and livelihoods. The number and variety of clinically approved antifungal drugs is very limited, and the emergence and rapid spread of resistance to these drugs means the impact of fungal infections will increase in the future unless alternatives are found. Despite the significance and major challenges associated with fungal infections, this topic receives significantly less attention than bacterial infections. A major challenge in the development of fungi-specific drugs is that both fungi and mammalian cells are eukaryotic and have significant overlap in their cellular machinery. This lack of fungi-specific drug targets makes human cells vulnerable to toxic side effects from many antifungal agents. Furthermore, antifungal drug resistance necessitates higher doses of the drugs, leading to significant human toxicity. There is an urgent need for new antifungal agents, specifically those that can limit the emergence of new resistant species. Non-drug nanomaterials have primarily been explored as antibacterial agents in recent years; however, they are also a promising source of new antifungal candidates. Thus, this article reviews current research on the use of inorganic nanoparticles as antifungal agents. We also highlight challenges facing antifungal nanoparticles and discuss possible future research opportunities in this field. STATEMENT OF SIGNIFICANCE: Fungal infections pose a growing threat to human health and livelihood. The rapid spread of resistance to current antifungal drugs has led to an urgent need to develop alternative antifungals. Nanoparticles have many properties that could make them useful antimycotic agents. To the authors' knowledge, there is no published review so far that has comprehensively summarized the current development status of antifungal inorganic nanomaterials, so we decided to fill this gap. In this review, we discussed the state-of-the-art research on antifungal inorganic nanoparticles including metal, metal oxide, transition-metal dichalcogenides, and inorganic non-metallic particle systems. Future directions for the design of inorganic nanoparticles with higher antifungal efficacy and lower toxicity are described as a guide for further development in this important area.
Insights
The limited effectiveness and rising resistance to antifungal drugs necessitate novel solutions. Inorganic nanoparticles show promise as new antifungal agents, offering a potential alternative to combat fungal infections.
Area of Science:
- Mycology
- Nanotechnology
- Materials Science
Background:
- Fungal infections present a significant global health challenge, exacerbated by limited treatment options and increasing drug resistance.
- Existing antifungal drugs face challenges due to toxicity and the emergence of resistant fungal strains.
- Developing targeted antifungal therapies is difficult because fungi and human cells share eukaryotic cellular machinery.
Purpose of the Study:
- To review the current research on inorganic nanoparticles as antifungal agents.
- To highlight the challenges and opportunities in the development of antifungal nanoparticles.
- To provide a comprehensive summary of antifungal inorganic nanomaterials, filling a gap in existing literature.
Main Methods:
- Review of current scientific literature on inorganic nanoparticles with antifungal properties.
- Categorization of nanoparticles discussed, including metal, metal oxide, transition-metal dichalcogenides, and inorganic non-metallic systems.
- Analysis of the potential of these nanomaterials as alternatives to conventional antifungal drugs.
Main Results:
- Inorganic nanoparticles demonstrate potential as effective antifungal agents.
- Various types of inorganic nanoparticles, including metal and metal oxide systems, are being explored for their antimycotic properties.
- Research indicates nanoparticles may offer advantages in overcoming drug resistance and reducing toxicity.
Conclusions:
- Inorganic nanoparticles represent a promising avenue for developing novel antifungal agents.
- Further research is needed to optimize nanoparticle design for enhanced antifungal efficacy and reduced host toxicity.
- Addressing challenges in nanoparticle development is crucial for combating the growing threat of fungal infections.
Related Concept Videos
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Chemical Agents for Microbial Control
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness

